Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (44)

« Back to Publications

Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study

Sigfrid L. et al, (2025), The Lancet Infectious Diseases, 25, 690 - 700

Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study

Kasbergen LMR. et al, (2025), The Lancet Infectious Diseases, 25, 678 - 689

Infrastructure, capabilities, and capacities required for clinical trials design and delivery: A rapid scoping review of recommendations and regulations

Merson L. et al, (2025), Wellcome Open Research, 9, 729 - 729

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

Mesinovic M. et al, (2024), Scientific Reports, 14

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Faust SN. et al, (2024), The Lancet Child & Adolescent Health, 8, 190 - 200

Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study

Cho S-M. et al, (2024), Brain Communications, 6

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Sandercock P. et al, (2024), Nature Communications, 15

Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study

Battaglini D. et al, (2024), Journal of Neurology, 271, 79 - 86

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19

Camirand-Lemyre F. et al, (2023), JAMA Network Open, 6, e2346502 - e2346502

Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?

Bourner J. et al, (2023), Trials, 24

A multi-country analysis of COVID-19 hospitalizations by vaccination status

Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.

Reyes LF. et al, (2023), Journal of critical care, 77

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

Wainstein M. et al, (2023), Kidney International Reports, 8, 1514 - 1530

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

Griffee MJ. et al, (2023), Research and Practice in Thrombosis and Haemostasis, 7, 102142 - 102142

Load More